CADTH Symposium 2016. The speaker has no financial or other conflicts of interest to report.

Slides:

Advertisements

Similar presentations

Blue Sky: Innovations in Patient Safety Teaching and Learning March 24 & 25, 2014 $50 Marriott Toronto Downtown Eaton Centre An event for health professionals.

Advertisements

All Payer Claims Database APCD Databases created by state mandate, that includes data derived from medical, eligibility, provider, pharmacy and /or dental.

There is no 'I' in RWE: (but there's a 'we'...): Opportunities and barriers to use of real-world evidence in Canada Presentation to: CADTH Symposiym, Saskatoon,

The evolving role of real-world evidence to support policy and practice CADTH 2015.

4 th Cutaneous Lymphoma Patient Educational Forum Saturday April 14, 2012 Cummings Auditorium Women's College Hospital.

SEBs – A Public Payer Perspective

Canadian Cancer Risk Management Model: A new health policy tool useful in policy decisions related to lung cancer WK Evans, M Wolfson, WM Flanagan, J Oderkirk,

Presented by: Deb Bulych, Director Supportive Care Patient Reported Outcomes (PRO)

© 2013 RNA Diagnostics Inc. All rights reserved. Confidential 1 “RDA: better chemotherapy management” Investor Presentation April 2013.

HTA from an Industry Perspective Janey Shin, Director of Medical Affairs Johnson & Johnson Medical Companies CADTH, 2015.

The Role of Patients in Defining “value” and Engaging in Drug Development from Bench to Bedside 1 CADTH Conference Concurrent Session A5 April 13, 2015.

Advancing Health Economics, Services, Policy and Ethics Reka Pataky CADTH Symposium, April 13, 2015.

YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.

1. 2 Implementing and Evaluating of an Evidence Based Nursing into Practice Prepared By Dr. Nahed Said El nagger Assistant Professor of Nursing H.

Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Jerry M. Maniate, MD, M.Ed, FRCPC Section of Haematology / Oncology, Department of Medicine St. Joseph’s Health Centre (Toronto) Assistant Professor, Faculty.

Health Provider Teams: How you can support cancer survivors after treatment Washington CARES about Cancer Partnership: Survivorship Taskforce June 2012.

Anne Hiltz, Director Pharmacy and Renal Program Nova Scotia Health Authority.

Value of Money in Cancer - IMRT as a case study

EXTENDING THE REACH OF THE RADIATION THERAPIST BEYOND THE TREATMENT FLOOR: QUALITY ASSURANCE COORDINATOR Brian Liszewski, M.R.T.(T.), BSc., Odette Cancer.

Ecdc.europa.eu European Cervical Cancer Summit Meeting Brussels, 22 January 2008 Professor Johan Giesecke Chief Scientist, ECDC ECDC Guidance for the Introduction.

Sep-15 Provincial Collaboration: The BC Injury Prevention Leadership and Action Network (BCIPLAN) Dobmeier, Teresa 1, ▪ Herman, Matt 2 ; Scott, Vicky 2.

Benchmarking Canadian HTA Agency and Provincial Payer Decision-Making Allen N. 1,2, Liberti L. 2, Salek M.S. 1 1 Centre for socioeconomic research, School.

Pharmacoeconomics Research Unit RESEARCH. DECISION SUPPORT. KNOWLEDGE TRANSLATION. CAPACITY BUILDING. Assessment of the pan-Canadian Oncology Drug Review.

Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)

Strategic Planning at Sunnybrook Creating a sustainable future for the organization and those we serve.

Supporting Informed Formulary Decision Making: CADTH’s Common Drug Review Denis Bélanger, Director, CADTH New Brunswick Stroke Summit November 27, 2010,

Cost-effectiveness of a Physical Activity Awareness Campaign Jennie Petersen, MSc. Student Dept. of Community Health Sciences Faculty of Medicine University.

International perspectives on human gene editing: South Africa KEYMANTHRI MOODLEY DIRECTOR & PROFESSOR CENTRE FOR MEDICAL ETHICS & LAW DEPARTMENT OF MEDICINE.

The Role of Perspective in Economic Evaluation for Cancer Prevention Steven Kymes, Ph.D. Research Associate Professor of Ophthalmology And Visual Sciences.

SEBs: Private Payer Perspective Carlyn Volume-Smith, B.Sc.Pharm., M.Sc., Ph.D. Senior Manager, Benefit Services.

REIMBURSEMENT, MARKET ACCESS & PRICING

The Opioid Addiction Treatment Database: Using administrative health data to conduct socially accountable research in the North Joseph K. Eibl, PhD and.

Professor Afaf Girgis Psycho-oncology Research Group Centre for Oncology Education and Research Translation Ingham Institute for Applied Medical Research,

Disease Pathway Management: Cancer Care Ontario’s Approach

Module 13: Information Systems The increasingly heavy reliance on healthcare informatics for medical technology, care systems, financial management, and.

Health Technology Assessment for Pharmaceuticals and New Medical Technologies - Where are we now? The industry perspective Jenny Hughes, Director, Vaccines.

Integrating Qualitative Research Into Health Technology Assessment in Canada The CADTH Experience Laura Weeks, PhD Scientific Advisor Kristen.

The HTA-Adoption (missing) Link for Medical Devices: Observations to Date Daria O’Reilly PhD Associate Professor, Dept. of Clinical Epidemiology & Biostatistics,

David M. Deci, M.D. Director Office of Medical Student Education Associate Professor, Department of Family Medicine University of Wisconsin School of Medicine.

Advancing Health Economics, Services, Policy and Ethics Stuart Peacock Cancer Control Research, BC Cancer Agency Canadian Centre for Applied Research in.

New Drug Approval on Prince Edward Island Iain Smith and Amanda Burke CADTH Symposium, Ottawa, ON

Gwendolyn Ryals, Look at Me Artwork from The Creative Center Janey Shin, Director, Real World Evidence Government Affairs and Market Access CADTH Symposium.

PROMs in reimbursement and real-world assessments of clinical interventions Stirling Bryan, PhD.

Expanding the Reach of Evidence in Nova Scotia Can we get the Evidence to Everyone? CADTH Symposium 2016 Lisa Farrell- Chair of DEANS ( NS Liaison CADTH)

Advancing Health Economics, Services, Policy and Ethics Collecting Real World Evidence: HTA’s perspective Dr. Kelvin Chan, MD FRCPC MSc (Clin Epi) MSc.

Annie Bilodeau Executive Director. Disclosure No conflict of interest.

Cancer Drug Funding Sustainability: From Recommendations to Action CADTH SYMPOSIUM 2016 Scott Gavura, Director, Provincial Drug Reimbursement Programs.

Real World Evidence in Cancer Care: A Payer’s Perspective CADTH SYMPOSIUM 2016 Scott Gavura, Director, Provincial Drug Reimbursement Programs.

New Methods in Generating Evidence for Everyone: Can we Improve Evidence Synthesis Approaches? CADTH symposium 2016.

“Disinvestment: What Does it Mean in the Canadian Context?” Public Payor Perspective CADTH Symposium April 2016 Chad Mitchell, MSc. Pharm A/Executive Director,

AN OVERVIEW: SAFER HEALTHCARE NOW! Canadian Patient Safety Institute Falls Faculty Meeting January 25 th, 2012 Theresa Fillatre.

Continuous Improvement & Real World Evidence: A Public Payer’s Perspective Suzanne McGurn, Assistant Deputy Minister and Executive Officer Ontario Public.

Alcohol, Cancer and Public Health

Craig Earle, MD MSc FRCPC

Variation in health state preferences across local and international populations: East doesn’t meet West CADTH symposium Panel Session April 12, 2016.

Clinical Leadership Decision Process

Palliative Care in Canada: History, Vision and Challenges

Dr. Simone Borsci DEC London

Health Strategies Group

Clinical Trials in STS Shreyaskumar Patel, M.D.

The relative importance of clinical, economic, social and organizational criteria in cancer drug reimbursement in Canada: A revealed preferences analysis.

Future Health Outlook April 23, 2018.

Collecting health equity info – in the shoes of patients and providers

Promotion on the Clinician Educator and Clinical Practice Tracks

Regulatory and Reimbursement Harmonization

Panelists & Moderator Dr. Tom O’Toole, Acting Senior Medical Advisor, Clinical Operations, Veterans Health Administration Karen Johnson, Senior Director,

COMPUS Overview Denis Bélanger Heather Bennett Steve Graham

“Managing Prostate Cancer Survivorship”

Engaging Stakeholders in the Development and Evaluation of the Aging, Community and Health Research Unit (ACHRU) – Community Partnership Program (CPP)

Presentation transcript:

CADTH Symposium 2016

The speaker has no financial or other conflicts of interest to report.

-Dr. Maureen Trudeau -Medical Oncologist at Sunnybrook Odette Cancer Centre, Professor of Medicine at the University of Toronto. Chair-elect of the Pan Canadian Oncology Expert Drug Review Committee(pERC). -Dr. Kelvin Chan -Medical Oncologist at Sunnybrook Odette Cancer Centre, Assistant Professor at U of T. Clinical lead Drug Reimbursement Programs at CCO. Member of OSSCD, Member of pCODR. -Dr. Stuart Peacock -Professor and Leslie Diamond Chair in Cancer Survivorship and Distinguished Scientist, Faculty of Health Science, Simon Fraser University. Co-Director of ARCC. -Scott Gavura, BScPhm, MBA, RPh. -Director, Provincial Drug Reimbursement Programs at CCO. -Dr. Craig Earle -Medical Oncologist at Sunnybrook Odette Cancer Centre, Director of Health Services Research for CCO and the Ontario Institute for Cancer Research. Professor of Medicine, U of T and Chair OSCCD, Member of pERC

Data from general populations of patients collected in a routine fashion: Evaluated against efficacy and cost-effectiveness estimates from the original studies Used to re-evaluate the uptake, benefit, toxicity, or budget impact assumptions Questions around RWE:  How do we collect it?  What infrastructure is needed?  How can provinces collaborate to produce this evidence?  What are the costs of and types of resources needed in collecting and analyzing real world evidence  How will this evidence be used to improve the quality of health care  Strategies to maximize health benefits while minimizing budget impact.

-Dr. Maureen Trudeau -Introduction -Dr. Kelvin Chan -Collecting Real World Evidence: HTA’s Perspective -Dr. Stuart Peacock -Real World Evidence: Research Approaches to Health Technology Management -Scott Gavura -Real World Evidence in Cancer Care: A Payer’s Perspective -Dr. Craig Earle -Routinely Collected Data (RDC) and ‘Adaptive’ Drug Reimbursement Arrangements

Dr. Kelvin Chan Collecting Real World Evidence: HTA’s Perspective

Dr. Stuart Peacock Real World Evidence: Research Approaches to Health Technology Management

Scott Gavura Real World Evidence in Cancer Care: A Payer’s Perspective

Dr. Craig Earle -Routinely Collected Data (RDC) and ‘Adaptive’ Drug Reimbursement Arrangements

Thank-You